Seeking Alpha

Merck (MRK) receives FDA approval to revise the biologics labeling on both the...

Merck (MRK) receives FDA approval to revise the biologics labeling on both the refrigerator-stable and frozen formulations of it's Chicken pox vaccine Varivax Details of the revised labeling aren't currently available.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector